Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
CBLC
Introduction
Signal transduction protein CBL-C is a protein that in humans is encoded by the CBLC gene.[1][2][3]
CBL proteins, such as CBLC, are phosphorylated upon activation of a variety of receptors that signal via protein tyrosine kinases. Through interactions with proteins containing SRC (MIM 190090) homology-2 (SH2) and SH3 domains, CBL proteins modulate downstream cell signaling (Keane et al., 1999).[supplied by OMIM][3]
Interactions
Interactions
CBLC has been shown to interact with FYN[4] and Epidermal growth factor receptor.[2][5]
References
References
- ↑ Keane MM, Ettenberg SA, Nau MM, Banerjee P, Cuello M, Penninger J, Lipkowitz S (Jun 1999). “cbl-3: a new mammalian cbl family protein”. Oncogene. 18 (22): 3365–75. doi:10.1038/sj.onc.1202753. PMID 10362357.
- ↑ 2.0 2.1 Kim M, Tezuka T, Suziki Y, Sugano S, Hirai M, Yamamoto T (Dec 1999). “Molecular cloning and characterization of a novel cbl-family gene, cbl-c”. Gene. 239 (1): 145–54. doi:10.1016/S0378-1119(99)00356-X. PMID 10571044.
- ↑ 3.0 3.1 “Entrez Gene: CBLC Cas-Br-M (murine) ecotropic retroviral transforming sequence c”.
- ↑ Kim, M; Tezuka T; Suziki Y; Sugano S; Hirai M; Yamamoto T (Oct 1999). “Molecular cloning and characterization of a novel cbl-family gene, cbl-c”. Gene. NETHERLANDS. 239 (1): 145–54. doi:10.1016/S0378-1119(99)00356-X. ISSN 0378-1119. PMID 10571044.
- ↑ Keane, M M; Ettenberg S A; Nau M M; Banerjee P; Cuello M; Penninger J; Lipkowitz S (Jun 1999). “cbl-3: a new mammalian cbl family protein”. Oncogene. ENGLAND. 18 (22): 3365–75. doi:10.1038/sj.onc.1202753. ISSN 0950-9232. PMID 10362357.
External links
External links
- Human CBLC genome location and CBLC gene details page in the UCSC Genome Browser.
Further reading
Further reading
- Ollendorff V, Mattei M, Fournier E, et al. (1999). “A third human CBL gene is on chromosome 19”. Int. J. Oncol. 13 (6): 1159–61. doi:10.3892/ijo.13.6.1159. PMID 9824625.
- Irby RB, Mao W, Coppola D, et al. (1999). “Activating SRC mutation in a subset of advanced human colon cancers”. Nat. Genet. 21 (2): 187–90. doi:10.1038/5971. PMID 9988270.
- Ettenberg SA, Keane MM, Nau MM, et al. (1999). “Cbl-b inhibits epidermal growth factor receptor signaling”. Oncogene. 18 (10): 1855–66. doi:10.1038/sj.onc.1202499. PMID 10086340.
- Loreto MP, Berry DM, McGlade CJ (2002). “Functional Cooperation between c-Cbl and Src-Like Adaptor Protein 2 in the Negative Regulation of T-Cell Receptor Signaling”. Mol. Cell. Biol. 22 (12): 4241–55. doi:10.1128/MCB.22.12.4241-4255.2002. PMC 133880. PMID 12024036.
- Szymkiewicz I, Kowanetz K, Soubeyran P, et al. (2002). “CIN85 participates in Cbl-b-mediated down-regulation of receptor tyrosine kinases”. J. Biol. Chem. 277 (42): 39666–72. doi:10.1074/jbc.M205535200. PMID 12177062.
- Courbard JR, Fiore F, Adélaïde J, et al. (2003). “Interaction between two ubiquitin-protein isopeptide ligases of different classes, CBLC and AIP4/ITCH”. J. Biol. Chem. 277 (47): 45267–75. doi:10.1074/jbc.M206460200. PMID 12226085.
- Wong ES, Fong CW, Lim J, et al. (2002). “Sprouty2 attenuates epidermal growth factor receptor ubiquitylation and endocytosis, and consequently enhances Ras/ERK signalling”. EMBO J. 21 (18): 4796–808. doi:10.1093/emboj/cdf493. PMC 126289. PMID 12234920.
- Taher TE, Tjin EP, Beuling EA, et al. (2002). “C-Cbl is involved in Met signaling in B cells and mediates hepatocyte growth factor-induced receptor ubiquitination”. J. Immunol. 169 (7): 3793–800. doi:10.4049/jimmunol.169.7.3793. PMID 12244174.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). “Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. Bibcode:2002PNAS…9916899M. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Nau MM, Lipkowitz S (2003). “Comparative genomic organization of the cbl genes”. Gene. 308: 103–13. doi:10.1016/S0378-1119(03)00471-2. PMID 12711395.
- Kim M, Tezuka T, Tanaka K, Yamamoto T (2004). “Cbl-c suppresses v-Src-induced transformation through ubiquitin-dependent protein degradation”. Oncogene. 23 (9): 1645–55. doi:10.1038/sj.onc.1207298. PMID 14661060.
- Kassenbrock CK, Anderson SM (2004). “Regulation of ubiquitin protein ligase activity in c-Cbl by phosphorylation-induced conformational change and constitutive activation by tyrosine to glutamate point mutations”. J. Biol. Chem. 279 (27): 28017–27. doi:10.1074/jbc.M404114200. PMID 15117950.
- Beausoleil SA, Jedrychowski M, Schwartz D, et al. (2004). “Large-scale characterization of HeLa cell nuclear phosphoproteins”. Proc. Natl. Acad. Sci. U.S.A. 101 (33): 12130–5. Bibcode:2004PNAS..10112130B. doi:10.1073/pnas.0404720101. PMC 514446. PMID 15302935.
- Rual JF, Venkatesan K, Hao T, et al. (2005). “Towards a proteome-scale map of the human protein-protein interaction network”. Nature. 437 (7062): 1173–8. Bibcode:2005Natur.437.1173R. doi:10.1038/nature04209. PMID 16189514.